RTTNews | Jan 5, 2021 07:14AM EST

07:13 Tuesday, January 5, 2021 (RTTNews) - BioXcel Says BXCL501 Meets Endpoints In TRANQUILITY Phase 1b/2 Study For Acute Treatment Of Agitation In Dementia

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved